PSMD2 and lung adenocarcinoma: Furthermore, as shown in Supplementary Table S1, univariate analysis showed that high expression of PSMD2 was significantly correlated with poor disease-specific survival of lung adenocarcinoma patients (HR 1.734, 95%CI, 1.198–2.512, p = 0.004).